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This article by Choi et al. describes the findings from 19 tertiary-care teaching hospitals in South Korea. At first, 
the finding that infectious diseases are attributed to 29% of all in-hospital deaths seems unexpected. Then we 
realize that the numbers, while surprising, are not unusual.
In the United States, hospital-acquired infections are a countrywide problem. It has been estimated that each 
year nearly two million patients get an infection while being treated in our nation’s hospitals, and almost 100,000 
of them die in the U.S. The Centers for Disease Control and Prevention estimates the cost of hospital-acquired 
infections to be as high as $27.5 billion each year.1 The findings in this study and elsewhere bring to light the fact 
that even the “most developed” countries, such as South Korea, the United Kingdom,2 and the United States, still 
face a constant and, in some cases, increasing threat from infection-related mortality in hospital settings. It is also 
interesting to note that pneumonia and septicemia remain the most common causes of death.
The sentinel hospital-based surveillance system is an important step toward developing and maintaining a use-
ful monitoring system to control routine and extraordinary infectious diseases. Other studies in the literature set 
up a standardized methodology for the mining and investigation of infection control surveillance.3 This article, 
however, is the first to evaluate the proportions of infectious diseases among all in-hospital mortality cases as 
either the direct or underlying cause of death and investigate the description of infectious causes of in-hospital 
death in South Korea. 
Mark Gregory Robson, PhD, MPH
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the mortality pattern was dominated by high rates 
of infectious disease-related deaths, especially in the 
young, although mortality from chronic diseases pre-
dominated. According to estimates from the Global 
Burden of Disease study, infectious diseases account for 
only 4% of all disability-adjusted life years (DALYs)—a 
measure of the burden of diseases and injuries—lost 
in countries with established market economies (e.g., 
the United States), whereas chronic and neoplastic 
diseases account for 81% of all DALYs.1
Until recently, it was assumed that the epidemiologic 
transition brought about a permanent reduction in 
infectious disease mortality in developed countries. 
However, emerging and reemerging diseases such as 
acquired immunodeficiency syndrome (AIDS) and 
tuberculosis (TB) demonstrate that gains against infec-
tious diseases cannot be taken for granted. Currently, 
avian influenza, which is caused by the influenza A virus 
(H5N1), continues to cause outbreaks among poultry 
and wild birds worldwide. These outbreaks have raised 
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During the 20th century, developing countries have 
experienced substantial declines in mortality and 
increases in life expectancy. In the 19th century, 
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serious global concerns about the imminent arrival of 
an influenza pandemic,2 making the surveillance of 
infectious diseases essential. 
Following the increase in emerging and reemerging 
infectious diseases since the late 1990s, the Korean 
government has strived to enhance its surveillance 
and response system. Since 2000, sentinel surveillance 
programs, such as the influenza sentinel surveillance, 
pediatric sentinel surveillance, school-based sentinel 
surveillance, and ophthalmological sentinel surveil-
lance programs, have been introduced to improve sur-
veillance activities. In 2007, we developed the sentinel 
hospital-based surveillance system for infection-related 
mortality. 
The immediate cause of mortality in patients with 
diverse underlying diseases can be infectious disease. 
However, the proportion of infectious diseases as 
either the immediate or underlying cause of mortality 
has not been clearly evaluated in Korea. This article 
describes the sentinel hospital-based surveillance sys-
tem for infection-related mortality and evaluates the 
proportions and characteristics of infectious diseases 
as either the immediate or underlying causes of in-
hospital mortality in Korea. 
METHODS
In 2007, the Korean Centers for Disease Control and 
Prevention and the Korean Society of Infectious Dis-
eases developed a sentinel hospital-based surveillance 
system for infection-related mortality. The sentinel 
hospital-based surveillance system consisted of 19 
tertiary-care teaching hospitals in Korea with nation-
wide distribution. The objectives of this surveillance 
system were to monitor outbreaks of severe infectious 
diseases and deaths by unidentified pathogens, evaluate 
the disease burdens of infectious diseases, and conduct 
multicenter clinical studies for infectious diseases. 
We retrospectively reviewed clinical data of patients 
who had in-hospital mortality from November 2007 
to May 2008. Infectious disease specialists evaluated 
the cause of death (COD) of each patient during the 
week of mortality. We defined infectious disease-related 
mortality as death that could be attributed to infectious 
disease as either the immediate or underlying cause. 
The term “immediate cause of death” is defined as the 
disease or injury directly leading to death, and the term 
“underlying cause of death” is defined as the disease 
or injury that initiated the sequence of events leading 
directly to death or the circumstances of the accident 
or violence that produced the fatal injury.3 In cases with 
infection-related mortality, infectious disease special-
ists defined the underlying and immediate causes of 
mortality according to standardized algorithms. Only 
one caused disease was entered in each cause. If the 
underlying COD was the same as the immediate COD, 
the codes were reintroduced in both causes. 
We used the International Classification of Diseases, 
10th Revision (ICD-10) codes to define underlying 
diseases and immediate causes of mortality.3 Individual 
assignments were subjective, as the ICD-10 codes are 
not well defined. For this article, we used a list of 28 
infectious CODs from the National Vital Statistics 
System at the Centers for Disease Control and Preven-
tion (CDC) for tabulation and analysis, although with 
modifications.4
We defined hospital-acquired infection as infec-
tion that occurred more than 48 hours after hospital 
admission, infection that occurred less than 48 hours 
after hospital admission in patients who had been 
hospitalized within two weeks prior to admission, or 
infection in patients who had been transferred from an 
outside hospital or nursing home. We also compared 
underlying diseases and immediate CODs between 
community- and hospital-acquired infections. 
We used Chi-square tests, Fisher’s exact tests, and 
linear-by-linear association to compare categorical 
variables as needed. We compared continuous variables 
using the student’s t -test. All p -values were two-tailed 
and we considered p0.05 to be statistically significant. 
We used SPSS® version 11.0 for this analysis.5
RESULTS
During the study period—November 4, 2007, to April 
26, 2008—there were 6,051 in-hospital mortality cases, 
1,756 of which were infection-related, accounting for 
29% of all in-hospital mortalities. Among these patients, 
685 were considered to have infectious diseases as 
underlying diseases, which was 16% of all in-hospital 
mortalities. The mean age of patients with infection-
related mortality was 65.4  17.2 years (range: 0–100), 
and 68% of patients with infection-related mortality 
were male (Table 1). The proportions of community- 
and hospital-acquired infections among infection-
related mortalities were 41% and 49%, respectively. 
In 10% of infection-related mortalities, we could not 
determine whether the infectious diseases were com-
munity acquired. There were 120 patients aged 0–39, 
777 aged 40–69, and 859 aged 70–109 (Table 2). We 
found a significant correlation between decade of 
life and proportion of community-acquired infection 
(p0.002). Demographic data on noninfectious mortal-
ity were not available during the study duration. 
As shown in Table 3, pneumonia was the most com-
mon underlying cause of infection-related mortality, 
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and septicemia was the most common direct cause 
of infection-related mortality. Table 4 shows com-
parisons between community- and hospital-acquired 
infection-related mortality. The mean age was higher 
in community-acquired infection-related mortality 
than in hospital-acquired infection-related mortality 
(p0.001). Septicemia was less common in community-
acquired infection-related mortality as the underlying 
cause of infection-related mortality. 
DISCUSSION
From the 1900s to the 1980s, the infectious disease 
mortality rate in developed countries declined sub-
stantially, consistent with the concept of epidemiologic 
transition.6 Epidemiologic transition is a phase of 
development witnessed by a sudden increase in popu-
lation growth rates brought about by medical innova-
tion in disease treatment, followed by a restabilization 
of population growth from subsequent declines in 
procreation rates. Improvements in living conditions, 
sanitation, and medical care probably accounted for 
this trend. However, during a 15-year period starting in 
1981, this trend reversed, with infectious disease deaths 
consistently increasing from year to year. At the end 
of the 20th century, infectious disease-related deaths 
declined again, largely because of a substantial decline 
in AIDS mortality.7 Emerging and reemerging diseases 
such as AIDS and TB account for the majority of the 
increased burden of infectious diseases worldwide. In 
Korea, up until the early 20th century, infectious dis-
eases were the major causes of morbidity and mortality. 
After 1950, the overall morbidity and mortality from 
infectious diseases rapidly declined.8 However, many 
emerging and reemerging communicable diseases, 
such as leptospirosis, malaria, endemic typhus, and 
brucellosis, have recently occurred in Korea.
The mortality statistics presented in this article were 
compiled in accordance with World Health Organiza-
tion regulations, which specify that member nations 
classify and code CODs in accordance with the cur-
rent version of the ICD-10. The ICD-10 provides the 
basic guidance used in virtually all countries to code 
and classify CODs. However, it does not classify infec-
tious diseases as similar codes. For example, codes for 
pneumonia contain A, B, or J codes. Additionally, we 
did not define each ICD-10 code. Therefore, we based 
the COD on the subjective opinions of infectious dis-
ease doctors. We should develop definitions for each 
of the ICD-10 codes for infectious diseases to monitor 
infection-related mortality objectively. 
In this six-month study, we evaluated the proportions 
of infectious diseases among all causes of mortality 
and described the causes of infection-related deaths. 
Infectious disease accounted for 29% of all in-hospital 
Table 1. Baseline characteristics of 1,756 deaths 
(29% of total deaths) related to infection at 
19 tertiary-care teaching hospitals in Korea, 
November 2007 to May 2008
Characteristic Value
Age (in years): mean ± SD (range) 65.4  17.2 (0–100)
Gender male: N (percent) 1,185 (68)
Community- or hospital-acquired 
infections: N (percent)
Community-acquired infections 718 (41)
Hospital-acquired infections 854 (49)
Undetermined 184 (10)
SD  standard deviation
Table 2. Age distribution of infection-related mortality at 19 tertiary-care teaching hospitals 
in Korea, November 2007 to May 2008 
Number of subjects





0–9 7 25 4 36
10–19 4 10 2 16
20–29 7 14 1 22
30–39 20 19 7 46
40–49 56 73 13 142
50–59 87 120 19 226
60–69 138 230 41 409
70–79 252 242 60 554
80–89 128 106 35 269
90–99 18 15 2 35
100–109 1 0 0 1
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mortalities, although it accounted for 16% of underly-
ing diseases. According to the Global Burden of Disease 
Study in 1990, in developed countries, infectious dis-
eases and respiratory infections accounted for a little 
more than 4% of DALYs, while in developing countries 
these same causes accounted for 35% of DALYs.1 Our 
study shows that infectious diseases account for substan-
tially large proportions of in-hospital mortalities. 
Limitations
Our study had several limitations. Although infection-
related mortality as an underlying cause was not so 
high, infection-related mortality as a direct or underly-
ing COD was substantially high. This finding could be 
related to the fact that we regarded death as infection-
related if either the direct or underlying COD was an 
infectious disease, and many patients who also have 
Table 3. Number of infection-related deaths for 28 possible causes at 19 tertiary-care teaching hospitals 














Certain other intestinal infections (A04, A07–9) 5 3 3 1
Tuberculosis (A15–19) 13 5 8 0
Respiratory tuberculosis (A15–16) 11 4 7 0
Other tuberculosis (A17–19) 2 1 1 0
Septicemia (A40–41) 35 264 70 291
Viral encephalitis (A83–86) 1 2 0 0
Viral hepatitis (B15–19) 1 0 2 0
Human immunodeﬁciency virus (B20–24) 5 0 1 1
Other and unspeciﬁed infectious and parasitic diseases and their 
sequelae (A00, A05, A20–36, A42–44, A48–49, A54–79, A81–82, 
A87–B04, B06–09, B25–49, B55–99) 10 8 13 8
Meningitis (G00, G03) 6 3 2 1
Acute and subacute endocarditis (I33) 3 2 2 1
Diseases of pericardium and acute myocarditis (I30–31, I40) 1 0 0 0
Inﬂuenza and pneumonia (J10–18) 141 210 175 277
Inﬂuenza (J10–11) 0 1 0 0
Pneumonia (J12–18) 141 209 175 277
Infections of the kidney (N10–12, N13.6, N15.1, N39.0) 18 8 2 7
Inﬂammatory diseases of female pelvic organs (N70–76) 0 0 0 1
aThere were no deaths from salmonella infections (A01–02), shigellosis and amebiasis (A03, A06), whooping cough (A37), scarlet fever and 
erysipelas (A38, A46), meningococcal infection (A39), syphilis (A50–53), acute poliomyelitis (A80), malaria (B50–54), rheumatic fever (I00–09), 
other acute lower respiratory infections (J20–22), acute bronchitis and bronchiolitis (J20–21), or unspeciﬁed acute lower respiratory infection 
(J22).
ICD-10  International Classiﬁcation of Diseases, 10th Revision
Table 4. Differences in causes of death between hospital- and community-acquired infection-related deaths 






Age (in years): mean  standard deviation 67.5  15.7 63.4  18.2 0.001
Gender male: N (percent) 481 (67) 592 (69) 0.328
Underlying causes: N (percent)
Septicemia (A40–41)a 35 (5) 70 (8) 0.008
Inﬂuenza and pneumonia (J10–18)a 141 (20) 175 (21) 0.704
Direct causes: N (percent) 
Septicemia (A40–41)a 264 (37) 291 (35) 0.264
Inﬂuenza and pneumonia (J10–18)a 210 (29) 277 (33) 0.187
aInternational Classiﬁcation of Diseases, 10th Revision codes
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noninfectious diseases die due to infectious diseases. 
Aside from this limitation, this finding revealed that 
infectious diseases are a major cause of in-hospital 
mortality in developed countries such as Korea. It is 
known that nosocomial infections contribute to 88,000 
deaths in U.S. hospitals annually.9 In our study, noso-
comial infections accounted for 49% of all infection-
related mortality cases. This finding showed that in 
developed countries, the occurrence of nosocomial 
infectious diseases contributes to the large burden of 
infectious diseases.
We performed this study during winter and early 
spring in a northern temperate climate; we did not 
evaluate the seasonality of infection-related mortality. 
Further studies should be conducted to evaluate its 
effect. Among infectious diseases, pneumonia and 
sepsis were the most common direct or underlying 
causes of infection-related deaths. This finding was 
consistent with other studies on disease burdens.1,4
The prognosis of many types of infectious diseases has 
consistently improved; however, the mortality rates of 
severe sepsis and pneumonia are still high, even in 
developed countries.10,11
There was only one death from influenza, although 
the six-month study period included the flu season in 
Korea. We assumed that mortality from influenza could 
be underestimated and classified as pneumonia. 
The causal relationship between mortality and dis-
ease was decided by the subjective opinions of infec-
tious disease specialists, and we did not define each 
ICD-10 code. Therefore, our results were not objective. 
We had data on numbers of deaths from infections at 
different ages but did not have the proportions of total 
deaths due to infection during these decades, so we 
could not know the age differences for the proportions 
of infection-related mortality clearly. 
In addition to these limitations, a sentinel surveil-
lance system is not representative of the entire popula-
tion, and this limitation should be considered before 
generalizing these findings. Moreover, because our 
study was conducted by tertiary-care hospitals, our 
results could be different from overall findings in 
Korea. We could not clearly differentiate a terminal 
infection in a patient who had inevitably deteriorat-
ing underlying disease from an unnecessary infec-
tious death as a complication of curable underlying 
disease. Further analyses along these lines should be 
performed.
CONCLUSIONS
Infectious diseases account for a substantially large 
proportion of in-hospital mortalities, even in devel-
oped countries such as Korea. Continuous surveillance 
of infection-related mortality would be helpful for 
monitoring outbreaks of severe infectious diseases and 
deaths by unidentified pathogens and evaluating the 
disease burdens of infectious diseases.
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